NOCIL.NS(NOCIL.NS)
NOCIL.NS
$190.30—Stale · unknown old
NSE • Last print unknown ago
$190.30—Stale · unknown old
No analyst ratings available
No analyst price targets available for NOCIL.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $15.16B | $17.57B | $17.90B |
| Low | $14.78B | $15.91B | $16.91B |
| High | $15.67B | $19.91B | $19.13B |
| EBITDA Avg | $1.79B | $2.30B | $2.28B |
| Low | $1.60B | $1.95B | $2.16B |
| High | $1.88B | $2.60B | $2.40B |
| EBIT Avg | $1.18B | $1.61B | $1.52B |
| Low | $989M | $1.26B | $1.40B |
| High | $1.27B | $1.91B | $1.64B |
| Net Income Avg | $895M | $1.22B | $1.16B |
| Low | $748M | $952M | $1.06B |
| High | $961M | $1.45B | $1.25B |
| EPS Avg | $4.90 | $6.80 | $6.85 |
| Low | $4.46 | $5.68 | $6.35 |
| High | $5.74 | $8.66 | $7.46 |
| Analysts (Rev / EPS) | 5 / 4 | 5 / 4 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $3.58B | $3.51B |
| Low | $3.58B | $3.51B |
| High | $3.58B | $3.51B |
| EBITDA Avg | — | — |
| Low | — | — |
| High | — | — |
| EBIT Avg | — | — |
| Low | — | — |
| High | — | — |
| Net Income Avg | — | — |
| Low | — | — |
| High | — | — |
| EPS Avg | — | — |
| Low | — | — |
| High | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — |